Virax Biolabs Group Limited Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Related Party Transactions (Tables)

Related Party Transactions (Tables)

12 Months Ended

Mar. 31, 2025


	As of March 31,
	2025		2024
Related Party Payables
James Foster	$	119,700	$	—
Jason Davis(1)		110,100		—
Nigel McCracken		107,776		—
Total Related Party Payables	$	337,576	$	—

(1) Jason Davis resigned from the Company on June 13, 2025.

Related party compensation for the Company's Officers and Directors for the years ended March 31, 2025, 2024 and 2023 are as follows:


	Year	Salary ($)		Bonus ($)		Option Awards ($) (1)		Other ($) (2)		Total ($)
James Foster, Chief Executive Officer and Director	2025		333,542		119,700		33,250		4,200		490,692
	2024		325,000		81,000		241,200		3,600		650,800
	2023		247,500		213,800		1,277,675		—		1,738,975
Nigel McCracken, Chief Operating Officer and Director	2025		315,051		107,776		33,250		25,209		481,286
	2024		175,000		50,000		71,600		3,540		300,140
	2023		—		—		—		—		—
Jason Davis, Former Chief Financial Officer(3)	2025		317,500		110,100		33,250		25,800		486,650
	2024		300,000		75,000		224,318		25,800		625,118
	2023		237,500		105,000		686,000		—		1,028,500
Evan Norton, Independent Director	2025		40,000		—		6,650		—		46,650
	2024		40,000		—		60,300		—		100,300
	2023		27,500		—		68,600		—		96,100
Yair Erez, Independent Director	2025		40,000		—		6,650		—		46,650
	2024		40,000		—		60,300		—		100,300
	2023		27,500		—		68,600		—		96,100
Nelson Haight, Independent Director	2025		40,000		—		6,650		—		46,650
	2024		40,000		—		60,300		—		100,300
	2023		14,783		—		27,400		—		42,183

(1) These amounts represent the aggregate grant fair value of stock options granted in the year ended March 31, 2025, 2024, and 2023 calculated in accordance with IFRS 2 “Share-based payment". Assumptions used in the calculation of these amounts are discussed in Note 16.

(2)These amounts represent employee benefits paid on behalf of the Company such as pension and health insurance.

(3)Jason Davis resigned from the Company effective June 13, 2025.